Windlas Biotech Ltd. (WINDLAS): Windlas Biotech Share Price hits fresh 52-week high on NSE

Windlas Biotech Share Price opened in focus at Rs 1,137.90, up 0.81% from the previous close of Rs 1,128.80, and touched a fresh 52-week high of Rs 1,151.65 as of 04 September 2026 at 9:33 AM IST. The company’s market capitalisation stood at Rs 2,256.57 crore, placing the move in a clear market-cap context for Windlas Biotech Share Price watchers. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst. What makes the move relevant is that the stock is now trading at its yearly high while the broader Windlas Biotech Share Price story remains anchored in measurable price action and valuation data.

For readers tracking Windlas Biotech Share Price today, the move is notable because the stock reached its 52-week peak early in the trading day and remained above its previous close. Windlas Biotech Stock News is therefore centred on the fresh high, the intraday range and the company’s fundamental profile rather than on any unverified trigger. Univest coverage keeps the discussion factual and helps place Windlas Biotech Share Price live within its Healthcare sector and Pharmaceuticals & Drugs industry context.

Windlas Biotech Share Price Today: Price Action Analysis

Windlas Biotech Ltd. (WINDLAS) traded at Rs 1,137.9 versus the previous close of Rs 1,128.8, a rise of 0.81%. The stock opened at Rs 1,130.45, reached a high of Rs 1,151.65 and touched a low of Rs 1,129.

Windlas Biotech Share Price today moved from an opening level of Rs 1,130.45 to an intraday high of Rs 1,151.65 and an intraday low of Rs 1,129.00. The stock last traded at Rs 1,137.90, a gain of Rs 9.10 over the previous close, and turnover stood at Rs 0.68 crore. Because the day high matched the 52-week high, the stock also printed a fresh one-year high during the trading morning. This is the core event behind the Windlas Biotech Share Price update.

The verified numbers show a narrow gap between the open and the high, and the stock stayed above the previous close after the initial move. For Windlas Biotech Share Price news, that is the main factual takeaway: the price has reached a new yearly high and is trading near that level. Investors tracking Windlas Biotech Share Price should now watch whether the stock continues to hold near its peak while the market digests the valuation and business metrics that follow.

Windlas Biotech Ltd. (WINDLAS) Fundamental Analysis

Windlas Biotech Ltd. (WINDLAS) fundamental metrics show P/E 35.05x, P/B 4.53x, ROE 12.52%, ROCE 16.06%. These figures provide context only and are not a buy or sell signal.

Windlas Biotech Ltd. has a market capitalisation of Rs 2256.57 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 35.05x, P/B at 4.53x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.52% and ROCE of 16.06%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 32.2, book value per share of Rs 249.16, dividend yield of 0.56%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.28x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Windlas Biotech Ltd. (WINDLAS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Windlas Biotech Ltd. (WINDLAS) has a P/E ratio of 35.05x, which is above the benchmark median of 32.28x, a difference of +8.58%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Windlas Biotech Ltd. (WINDLAS) has a ROE of 12.52%, which is above the benchmark median of 11.78%, a difference of +6.28%. Windlas Biotech Ltd. (WINDLAS) has a ROCE of 16.06%, which is above the benchmark median of 13.65%, a difference of +17.66%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Windlas Biotech Ltd. (WINDLAS) has a P/E ratio of 35.05x compared with the displayed peer median of 60.56x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.52% compares with a peer median of 16.09% across the companies shown in the table. ROCE stood at 16.06% versus the displayed peer median of 21.34%, providing a capital-efficiency comparison. Windlas Biotech Ltd. (WINDLAS) has a market capitalisation of Rs 2,256.57 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Windlas Biotech

• Windlas Biotech Share Price touched a fresh 52-week high of Rs 1,151.65 during the trading morning.
• The stock last traded at Rs 1,137.90, up Rs 9.10 or 0.81% from the previous close.
• Market capitalisation stood at Rs 2,256.57 crore for Windlas Biotech Share Price.
• The company’s P/E ratio is 35.05 and P/B ratio is 4.53.
• ROE is 12.52%, ROCE is 16.06%, EPS is 32.2 and dividend yield is 0.56%.

About Windlas Biotech

Windlas Biotech Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For Windlas Biotech Share Price readers, the most useful company context today is the combination of its business classification, its current market capitalisation and the financial metrics already visible in the latest data. Univest keeps the focus on verified figures so the Windlas Biotech Share Price story remains rooted in measurable company information.

Frequently Asked Questions

Why did Windlas Biotech Share Price hit a fresh 52-week high?

Ans. Windlas Biotech Share Price touched Rs 1,151.65 during the trading morning, which is the fresh 52-week high. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst.

What is Windlas Biotech Share Price today?

Ans. Windlas Biotech Share Price last traded at Rs 1,137.90, which was Rs 9.10 above the previous close of Rs 1,128.80. That keeps the stock above the prior session’s settlement as it trades near its high.

What was the highest price seen in Windlas Biotech Share Price today?

What is Windlas Biotech Share Price market capitalisation?

Ans. Windlas Biotech Share Price has a market capitalisation of Rs 2,256.57 crore. That places the company above the industry median market cap of Rs 723.58 crore in the Healthcare benchmark.

Is Windlas Biotech Share Price expensive or cheap on valuation?

Ans. Windlas Biotech Share Price trades at a P/E of 35.05 and a P/B of 4.53. Versus the industry median P/E of 32.28 and median P/B of 2.85, it is not priced below the benchmark.

How do Windlas Biotech fundamentals look?

Ans. Windlas Biotech Share Price is backed by ROE of 12.52%, ROCE of 16.06%, EPS of 32.2, book value of Rs 249.16 and dividend yield of 0.56%. Revenue also rose across the latest reported quarters.

How does Windlas Biotech compare with peers?

Ans. Windlas Biotech Share Price sits in a peer set where some companies trade at lower P/E ratios and higher return ratios. Its market cap is broadly similar to several listed peers in Pharmaceuticals & Drugs.

Where can I track Windlas Biotech Share Price news?

Ans. You can track Windlas Biotech Share Price on Univest for live price updates, market cap, valuation ratios, earnings metrics, sector context and peer comparison. That helps consolidate Windlas Biotech Stock News and Windlas Biotech Share News.

Track Windlas Biotech Share Price on Univest

Use Windlas Biotech Ltd. (WINDLAS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Windlas Biotech Share Price live on Univest for current price updates, 52-week levels, market capitalisation, valuation ratios, earnings metrics, sector context and peer comparison. Univest also helps users follow Windlas Biotech Stock News and Windlas Biotech Latest News in one place.